Iradimed (IRMD) Free Cash Flow Growth (5y) (2018 - 2026)
Iradimed (IRMD) Free Cash Flow Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Iradimed | 1.11 Bn | 1.05 Bn | 15.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.70% |
| Mar 31, 2026 | 54.31% |
| Dec 31, 2025 | 16.25% |
| Sep 30, 2025 | 39.49% |
| Jun 30, 2025 | 43.68% |
| Mar 31, 2025 | -10.39% |
| Dec 31, 2024 | -3.86% |
| Sep 30, 2024 | 10.66% |
| Jun 30, 2024 | 18.07% |
| Mar 31, 2024 | 41.17% |
| Dec 31, 2023 | 24.24% |
| Sep 30, 2023 | 13.19% |
| Jun 30, 2023 | -31.17% |
| Mar 31, 2023 | 23.74% |
| Dec 31, 2022 | 16.81% |
| Sep 30, 2022 | 24.27% |
| Jun 30, 2022 | 38.72% |
| Mar 31, 2022 | 54.23% |
| Dec 31, 2021 | 11.94% |
| Sep 30, 2021 | -1.31% |